Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U. Wells, Daniel F. Dilling, Rainer-Georg Goeldner et al.|The Lancet Respiratory Medicine|2020Cited by 558
A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodulesBenjamin Hunter, Richard W. Lee, Mitchell Chen et al.|EBioMedicine|2022Cited by 46
Hiatus hernia and interstitial lung abnormalitiesPeter M. George, Gary M. Hunninghake, Tomoyuki Hida et al.|European Respiratory Journal|2020Cited by 8
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew Creamer, Sam M. Janes, Carolyn Horst et al.|Thorax|2025Cited by 3
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang et al.|Nicotine & Tobacco Research|2025Cited by 2